Business vertical-focused learning solutions for the health care industry launched by TIS

Global learning solutions provider-Tata Interactive Systems (TIS)-has recently announced the launch of its first business vertical-focused learning solutions for organizations in the health care industry. TIS formally launched this initiative with the appointment of Candida Chandorkar as Vice President - Global Healthcare Solutions, a move from her earlier position as Vice President - ANZ.

TIS has previously developed learning programs for clients in the healthcare industry-including GlaxoSmithKline; The American College of Sports Medicine; The Imperial College, London; The New York Presbyterian Hospital; St John; and Lippincott Williams & Wilkins. Now, with the launch of this specific business vertical and drawing from their 19 years' experience of developing learning solutions, TIS will provide focused consulting and learning solutions to effectively address the requirements of this industry.

According to Candida Chandorkar, "As a consequence of rapid advancements in medical science and technology, this industry is constantly addressing new challenges. Our aim is to partner with Healthcare, Pharmaceutical and Biotechnology organizations in their key initiatives to address strategic challenges that include building a flexible and talented workforce, new technology introduction, and sustainable development.

"We feel excited and confident that our innovative and cutting-edge learning solutions can enable the success of these key initiatives through immersive business simulations for leadership development and process optimization, enterprise applications training for IT implementations, performance optimization solutions, as well as e-learning solutions using the newer formats such as serious games and virtual worlds."

Speaking about the strategic move, Urs Widmer - Vice President, TIS AG says, "We are optimistic that our experience of working with the health care and pharmaceutical sector will help us focus on industry-specific innovative offerings. This approach marks a new direction for us and our plan is to not only continue working with existing markets like Switzerland, but also venture into other potential markets to help address the ever-increasing need of knowledge in the Healthcare, Pharmaceutical, and Biotechnology industry."